← FDA Drug Approvals (Drugs@FDA)
DAPIPRAZOLE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARADAINA LLC · Approved 2019-05-29
Drug application
- FDA Application #
ANDA204902- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPIPRAZOLE HYDROCHLORIDE
- Generic name
- Dapiprazole Hydrochloride
- Active ingredients
- DAPIPRAZOLE HYDROCHLORIDE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- BARADAINA LLC
- First approval
- 2019-05-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown